Atika Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-85,000	Closed	-$4.85M	–	82
2023 Q3	$4.85M	Buy	+85,000	New	+$4.85M	0.64%	52